You are currently viewing a new version of our website. To view the old version click .
Pharmaceutics
  • Correction
  • Open Access

19 January 2023

Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511

,
,
,
,
,
,
,
,
and
1
Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Miaoli 35053, Taiwan
2
Institute of Biomedical Sciences, Academia Sinica, Taipei 115021, Taiwan
3
Institute of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei 10617, Taiwan
4
National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan
Changes to “authors who contributed equally”
In the original publication [1], the authors who had “contributed equally” were not listed. The corrected statement appears here. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Lee, Y.-Z.; Hsu, H.-Y.; Yang, C.-W.; Lin, Y.-L.; Chang, S.-Y.; Yang, R.-B.; Liang, J.-J.; Chao, T.-L.; Liao, C.-C.; Kao, H.-C.; et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.